Hologic Inc. logo

Hologic Inc. (HOLX)

Market Closed
5 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
74. 97
+0.11
+0.15%
$
16.67B Market Cap
38.79 P/E Ratio
0% Div Yield
1,652,346 Volume
3.91 Eps
$ 74.86
Previous Close
Day Range
74.83 75.09
Year Range
51.9 80.31
Want to track HOLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 59 days
Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report?

Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report?

Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 1 year ago
Should You Bet on HOLX Stock This Breast Cancer Awareness Month?

Should You Bet on HOLX Stock This Breast Cancer Awareness Month?

October is celebrated as breast cancer awareness month annually, and Hologic HOLX, this time too, honored the occasion by ringing the Nasdaq opening bell for the 18th consecutive time. While celebrating this yearly tradition, the company came into the limelight as it also introduced a comprehensive education campaign aimed at debunking common myths about breast cancer, mammograms and breast density.

Zacks | 1 year ago
Hologic (HOLX) Rises Yet Lags Behind Market: Some Facts Worth Knowing

Hologic (HOLX) Rises Yet Lags Behind Market: Some Facts Worth Knowing

Hologic (HOLX) closed at $80.26 in the latest trading session, marking a +0.48% move from the prior day.

Zacks | 1 year ago
Hologic (HOLX) Stock Sinks As Market Gains: Here's Why

Hologic (HOLX) Stock Sinks As Market Gains: Here's Why

Hologic (HOLX) reachead $79.77 at the closing of the latest trading day, reflecting a -0.98% change compared to its last close.

Zacks | 1 year ago
Hologic CEO Steve MacMillan on breast cancer detection, future of AI-powered diagnostics

Hologic CEO Steve MacMillan on breast cancer detection, future of AI-powered diagnostics

Steve MacMillan, Hologic chairman, president and CEO and Illumina chairman, joins 'Squawk Box' to discuss breast cancer awareness month, impact of AI on breast cancer detection, AI-powered diagnostics and the future of healthcare, and more.

Youtube | 1 year ago
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 1 year ago
HOLX Stock Gains From New Offerings Despite Macro Issues

HOLX Stock Gains From New Offerings Despite Macro Issues

In Breast Health, Hologic expands its product offering from imaging to cover the continuum of breast cancer care, including biopsy and surgery.

Zacks | 1 year ago
Is HOLX Stock a Smart Hold for Your Portfolio Right Now?

Is HOLX Stock a Smart Hold for Your Portfolio Right Now?

Hologic's strength in Molecular Diagnostics is highly promising. Yet, macroeconomic uncertainties can pose headwinds for its operations.

Zacks | 1 year ago
Here's Why Hologic (HOLX) is a Strong Value Stock

Here's Why Hologic (HOLX) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Hologic (HOLX) Falls More Steeply Than Broader Market: What Investors Need to Know

Hologic (HOLX) Falls More Steeply Than Broader Market: What Investors Need to Know

In the closing of the recent trading day, Hologic (HOLX) stood at $81.39, denoting a -1.23% change from the preceding trading day.

Zacks | 1 year ago
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks | 1 year ago
Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term

Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Loading...
Load More